ISPE Highlights
Pharmaceutical Engineering Magazine
Highlights From ISPE Knowledge Network
- Explore the Future of Radiopharmaceuticals, High Potency Compounds, and Facility Design at the ISPE Aseptic Conference
- Is Aseptic Processing at Risk? Navigating New Demands
- Aseptic Innovation in Focus: 2025 Session Takeaways Ahead of the 2026 ISPE Aseptic Conference
- Electrical Area Classification in Biotech and Manufacturing Facilities
- Introducing the AI Community of Practice (CoP) Regulatory Subcommittee: Enabling AI in Pharma through Regulatory Knowledge
- Advancing Toward Continuous Validation with a Data-Centric Strategy
- Maturing AI in Life Sciences: Building Infrastructure, Not Experiments
- Recap: Predictions and Reflections - Future of Pharma Innovations
- AI in Workforce Readiness
- Shaping the Future of the Next Generation of Pharma Leaders
- ISPE Nordic Annual Meeting 2026: AI, Innovation Highlights, Plus a Preview of the 2026 ISPE Europe Annual Conference
- Shaping Skills for a Changing Pharma Landscape: ISPE’s Professional Development Pathways
- Explore the Future of Radiopharmaceuticals, High Potency Compounds, and Facility Design at the ISPE Aseptic Conference
- AI in Workforce Readiness
- Continuous Biomanufacturing (CBM) of Large Molecule Drug Substances-Guidance
- The Laboratory Automation Plug and Play (LAPP) Framework – The Case for Standardization in Research and Development (R&D) and Quality Control (QC) Laboratories: Part Three
- Re-imagining Inspection/Audit Response Writing with Generative AI (GenAI)
- Elevating Quality Excellence in the Netherlands: Introducing the ISPE Netherlands Affiliate Quality Community of Practice (CoP)
- Advancing Toward Continuous Validation with a Data-Centric Strategy
- Elevating Quality Excellence in the Netherlands: Introducing the ISPE Netherlands Quality Community of Practice (CoP)
- Crisis Management and Partnership with US Food and Drug Administration (US FDA): North Cove’s Recovery After Hurricane Helene
- Re-imagining Inspection/Audit Response Writing with Generative AI (GenAI)
- Navigating the US Food and Drug Administration (US FDA) Outsourcing Facility Inspections Compliance Program
- Pharma 4.0™ Needs More than Technology: A Holistic Blueprint for Digital Enablement
- ISPE Experts Join National Dialogue on Drug Supply Chain Security
- Harmonization in Validation: Balancing Global Standards with Local Needs
- Accelerating Pharma Manufacturing: Automation and Robotics in Pharma 4.0™
- PAT as a Catalyst for Digital Transformation: Lessons for Engineers and Pharma Professionals at the 2025 ISPE Pharma 4.0™ Conference
- Explore the Future of Radiopharmaceuticals, High Potency Compounds, and Facility Design at the ISPE Aseptic Conference
- Is Aseptic Processing at Risk? Navigating New Demands
- Aseptic Innovation in Focus: 2025 Session Takeaways Ahead of the 2026 ISPE Aseptic Conference
- Electrical Area Classification in Biotech and Manufacturing Facilities
- Introducing the AI Community of Practice (CoP) Regulatory Subcommittee: Enabling AI in Pharma through Regulatory Knowledge
- Advancing Toward Continuous Validation with a Data-Centric Strategy
- Maturing AI in Life Sciences: Building Infrastructure, Not Experiments
- Recap: Predictions and Reflections - Future of Pharma Innovations
- AI in Workforce Readiness
- Shaping the Future of the Next Generation of Pharma Leaders
- ISPE Nordic Annual Meeting 2026: AI, Innovation Highlights, Plus a Preview of the 2026 ISPE Europe Annual Conference
- Shaping Skills for a Changing Pharma Landscape: ISPE’s Professional Development Pathways
- Explore the Future of Radiopharmaceuticals, High Potency Compounds, and Facility Design at the ISPE Aseptic Conference
- AI in Workforce Readiness
- Continuous Biomanufacturing (CBM) of Large Molecule Drug Substances-Guidance
- The Laboratory Automation Plug and Play (LAPP) Framework – The Case for Standardization in Research and Development (R&D) and Quality Control (QC) Laboratories: Part Three
- Re-imagining Inspection/Audit Response Writing with Generative AI (GenAI)
- Elevating Quality Excellence in the Netherlands: Introducing the ISPE Netherlands Affiliate Quality Community of Practice (CoP)
- Advancing Toward Continuous Validation with a Data-Centric Strategy
- Elevating Quality Excellence in the Netherlands: Introducing the ISPE Netherlands Quality Community of Practice (CoP)
- Crisis Management and Partnership with US Food and Drug Administration (US FDA): North Cove’s Recovery After Hurricane Helene
- Re-imagining Inspection/Audit Response Writing with Generative AI (GenAI)
- Navigating the US Food and Drug Administration (US FDA) Outsourcing Facility Inspections Compliance Program
- Pharma 4.0™ Needs More than Technology: A Holistic Blueprint for Digital Enablement
- ISPE Experts Join National Dialogue on Drug Supply Chain Security
- Harmonization in Validation: Balancing Global Standards with Local Needs
- Accelerating Pharma Manufacturing: Automation and Robotics in Pharma 4.0™
- PAT as a Catalyst for Digital Transformation: Lessons for Engineers and Pharma Professionals at the 2025 ISPE Pharma 4.0™ Conference
Explore the benefits of ISPE membership.